Skip to main content
Livermore
Livermore
ZHEN

Qube Research & Technologies Ltd

SEC CIK
0001729829
Latest filing
Aug 14, 2026

TAK holding history

Takeda Pharmaceutical Co Ltd in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TAK overviewAll 13F holders of TAKFull Q2 2026 holdings

Shares (Q2 2026)
2,207,432
Value
$35.4M
% of portfolio
<0.1%
Quarters held
16
Since Q1 2021
Holdings of TAK by Qube Research & Technologies Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,207,432$35.4M<0.1%+2,207,432NewHolders
Q1 20260$00.0%−197,507−100.0%Sold outHolders
Q4 2025197,507$3.08M<0.1%−1,578,338−88.9%ReducedHolders
Q3 20251,775,845$26.0M<0.1%+1,426,184+407.9%AddedHolders
Q2 2025349,661$5.41M<0.1%+55,962+19.1%AddedHolders
Q1 2025293,699$4.37M<0.1%+113,761+63.2%AddedHolders
Q4 2024179,938$2.38M<0.1%+49,821+38.3%AddedHolders
Q3 2024130,117$1.85M<0.1%+130,117NewHolders
Q2 20240$00.0%−114,209−100.0%Sold outHolders
Q1 2024114,209$1.59M<0.1%−319,309−73.7%ReducedHolders
Q4 2023433,518$6.19M<0.1%+146,813+51.2%AddedHolders
Q3 2023286,705$4.44M<0.1%−444,953−60.8%ReducedHolders
Q2 2023731,658$11.5M<0.1%+394,761+117.2%AddedHolders
Q1 2023336,897$5.55M<0.1%+336,897NewHolders
Q2 20220$00.0%−218,322−100.0%Sold outHolders
Q1 2022218,322$3.13M<0.1%+15,874+7.8%AddedHolders
Q4 2021202,448$2.76M<0.1%+7,368+3.8%AddedHolders
Q3 2021195,080$3.19M<0.1%+195,080NewHolders
Q2 20210$00.0%−188,713−100.0%Sold outHolders
Q1 2021188,713$3.45M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.